Molecular Alterations in Lung Cancer – Beyond EGFR, ALK and ROS1
<p>Lung cancer is a leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) comprising nearly 85% of cases and showing a rising incidence globally, including in India. Over the last two decades, the identification of actionable oncogenic driver alterations has transf...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2026
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/1230396 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Molecular Alterations in Lung Cancer – Beyond EGFR, ALK and ROS1
- Targeting EGFR and HER2 for Molecular Imaging of Cancer
- Exploring Gene Regulatory Interaction Networks and predicting therapeutic molecules for Hypopharyngeal Cancer and EGFR-mutated lung adenocarcinoma
- Beyond VEGF: The NOTCH and ALK1 Signaling Pathways as Tumor Angiogenesis Targets
- EGFR Mutation Prediction of Lung Biopsy Images using Deep Learning
- Anti-EGFR Treatment in Patients with Colorectal Cancer
- OncoTraj: a public benchmark for longitudinal resistance prediction in EGFR-mutant non-small-cell lung cancer on osimertinib